-
Detection of Beta-Blockers in Urine and Serum by Solid-Phase Extraction-Supercritical Fluid Extraction and Gas Chromatography-Mass Spectrometry
Time of Update: 2021-03-05
Beta-blockers have some clinical use in the treatment of angina pectoris, hypertension, and tachycardia. In addition, they have been used to control migraine, chronic alcoholism, schizophrenia, essential tremor, and cardiac effects
-
Jilin Petrochemical has built a styrene blocker evaluation device
Time of Update: 2021-02-24
China Coatings Network News: Jilin Petrochemical Research Institute styrene blocker evaluation device has been completed, with the plant evaluation of the whole process simulation test conditions, the project has entered the pilot production and industrialization application stage.
-
JAMA Neurol: The relationship between α-1 blockers and the risk of Parkinson's disease
Time of Update: 2021-02-24
In order to determine whether tracosin, dosazine, and aphdone were associated with a reduced risk of Parkinson's disease, researchers tested this hypothesis using data from two large administrative health care databases in the United States and Denmark.
-
Jihua built a styrene blocker evaluation device
Time of Update: 2021-02-23
China Coatings Network News: Jilin Petrochemical Research Institute styrene blocker evaluation device has been completed, with the plant evaluation process simulation test conditions, the project has entered the pilot production and industrialization application stage.
-
The pharmaceutical giant has bet on cellular immunotherapy. Is spring back?
Time of Update: 2021-02-21
Pharma also announced the establishment of a Sino-foreign joint venture with Kite Pharma to study immunotherapy for lymphoma. The pharmaceutical giant has invested heavily in immunotherapy, is its spring back? A number of investments
-
The growth of multinational pharmaceutical companies such as Johnson and Johnson is weak, betting on innovative drugs
Time of Update: 2021-02-20
showed that roche achieved a net profit of 5.57 billion Swiss francs (4.92 billion euros) in the first half of this year, up 2% YoY; Schwan, president of the Roche Group, said the pharmaceutical and diagnostic divisions had both achieved good
-
Beda Pharmaceuticals Class 1 new drug BET inhibitors were approved clinically
Time of Update: 2021-01-31
Screenshot Source: CDE Official Website According to the announcement issued by Beda Pharmaceuticals, BPI-23314 is a new molecular solid compound developed by it, is a new type of strong, selective bromine domain and oral small molecule inhibitor
-
inhibitors or angiotensin II blockers due to neocycline pneumonia factors
Time of Update: 2021-01-26
Recently, researchers examined the effects of stopping or continuing to receive angiotensin-converting enzyme inhibitors (ACEIs) or angiotensin II blockers (ARBs) on the prognosis of 30-day neocycline pneumonia in patients with COVID-19 with high blood pressure.
-
Hypertension: Relationship between calcium channel blockers and the risk of active TB
Time of Update: 2021-01-01
Iron, an important mineral of intracerine pathogens, reduces the biousing of iron by calcium channel blockers (CBBs). , it is not clear whether the use of CCCB in clinical practice will alter the risk of active TB. , a study published
-
Science Sub-Journal Reveals: Secret Weapon to Suppress Tumor Recurrence - β Blocker Blocker
Time of Update: 2020-12-22
the inflammatory S100A8/A9 protein in large quantities through beta-2-adrenaline. S100A8/A9 induces myelin peroxidase (MPO) to be active, causing lipid oxide to accumulate in neutral granulocytes. after the release of lipid oxide, the fibroblast
-
Innovative SARS-CoV-2 blockers completely prevent cell infections
Time of Update: 2020-12-16
this, Formycon uses a computer-aided structural design to bind the human ACE2 protein to the human antibody component, resulting in a very effective SARS-CoV-2 blocker called ACE2-IgG-Fc.
-
MrRNA under the wind, a big bet or the next Nobel Prize?
Time of Update: 2020-12-15
discovery didn't make much of a splash at the time, it caught the attention of two characters. , the two men founded Moderna and BioNTech, two giants in the mRNA field. , Moderna has focused on new nucleotide modification technologies and has
-
A bet on Harvard University's anti-fouling paint technology innovation
Time of Update: 2020-12-12
of adhesive proteins were found on all control coating surfaces. to see if mussels continued to try to secrete foot silk, the researchers placed them on the surface of each model and observed them in real time. On impermeable LBL and PDMS
-
What exactly is the CD47 that attracts AbbVie to bet on the creatures of heaven and earth?
Time of Update: 2020-11-15
Overnight, innovative oncology immunotherapy grabbed the headlines again, but this time it was no longer PD-(L)1, but CD47. September 4th, The Life of Heaven (IMAB. NASDQ and AbbVie have jointly announced an extensive global strategic
-
The national team's rapid layout MNC heavy gold bet: standing in the air mouth of the medical big data will go where
Time of Update: 2020-11-15
joint venture proposed the name of China Pharmaceutical Intelligent Technology (Shanghai) Co., Ltd., after the establishment of the joint venture, will invest in the construction of a national medical and pharmaceutical emergency protection system Internet platform company.
-
Under the Internet medical wind, multinational pharmaceutical companies have bet on this field
Time of Update: 2020-11-15
/>, for example, on February 13th Ali Health announced the launch of a "Slow Disease Benefits Program" with 50 pharmaceutical companies, covering thousands of drugs from more than 10 common diseases. At present, in general, many pharmaceutical companies
-
Sea King Bio announced that a new type of tumor vascular blocker has been approved for clinical use in China.
Time of Update: 2020-10-27
Retrieved Oct 22, 2020, from the Sea King Research Institute, another innovative drug, HW130 injections, was approved by the FDA to enter human clinical trials.
-
$480 million! Pfizer is betting heavily on Keystone Pharmaceuticals' big three spots.
Time of Update: 2020-10-24
shows that Pfizer, in addition to its Shugli single-resistance commercialization potential in China, also values the research and development of keystone pharmaceutical industry, especially the strength of clinical development.
-
Wenda Pharmaceutical BET inhibitors were approved clinically.
Time of Update: 2020-10-15
obtained two clinical tacit licenses in China to develop treatments for advanced recurrence of non-Hodgkin's lymphoma, skin/mucosal melanoma, non-small cell lung cancer and small cell lung cancer. NHWD-870 is a new, powerful BET inhibitor
-
J Hepatology: β-term hemodynamic effects of the adhesive blocker can have a negative effect on the survival of patients with disproparated cirrhosis.
Time of Update: 2020-10-12
in patients with high-risk varicose veins and disproflated cirrhosis, β-blockers responded more to the systemic hemodynamics and had smaller venous pressure drops.
